Yan Luo

Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade

B. Necela, K. Knutson, M. Cannon, 2023, Journal for ImmunoTherapy of Cancer.

Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far?

M. Kharfan-Dabaja, M. Gadd, Ricardo D. Parrondo, 2023, Clinical hematology international.

Targeting chronic lymphocytic leukemia with B‐cell activating factor receptor CAR T cells

M. Kharfan-Dabaja, F. Yassine, M. Gadd, 2024, MedComm.